FDA.reportPublic FDA data

aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]

RxCUI
994239
RxNorm name
aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]
Display name
aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]
Full name
aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ascomp with CodeineBUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATEBreckenridge Pharmaceutical, Inc.243a6aea-0f48-42a9-a85e-ff247ab943362026-02-09Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 994239
Ascomp with CodeineBUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATELGM PHARMA SOLUTIONS, LLC1cab3106-1064-4b42-892b-39f405d9e02f2025-11-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 994239

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1cab3106-1064-4b42-892b-39f405d9e02fAscomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp] [SBD] · ASA 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Ascomp] [SY] · Ascomp with Codeine (ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule [SY]415These highlights do not include all the information needed to use Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP safely and effectively. See full prescribing information for Butalbital, Aspirin, Caffe i ne, and Codeine Phosphate Capsules, USP . B utalbital, A spirin, C affeine, and C odeine P hosphate C apsules, USP for oral use, CIII Initial U.S. Approval: 199020251101
243a6aea-0f48-42a9-a85e-ff247ab94336Ascomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp] [SBD] · ASA 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Ascomp] [SY] · Ascomp with Codeine (ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule [SY]413These highlights do not include all the information needed to use ASCOMP with Codeine safely and effectively. See full prescribing information for ASCOMP with Codeine. ASCOMP with Codeine (butalbital, aspirin, caffeine, and codeine phosphate, USP) capsules, for oral use, CIII Initial U.S. Approval: 199020260209
ca3fe6e9-21ad-4fba-a602-e1c364cf3981Ascomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule [PSN] · aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp] [SBD] · ASA 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Ascomp] [SY] · Ascomp with Codeine (ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule [SY]411These highlights do not include all the information needed to use ASCOMP with CODEINE (Butalbital, Aspirin, Caffeine, and Codeine Phosphate, USP Capsules) safely and effectively. See full prescribing information for ASCOMP with CODEINE (Butalbital, Aspirin, Caffeine, and Codeine Phosphate, USP) capsules, for oral use, CIII Initial U.S. Approval: 199020200212